157 related articles for article (PubMed ID: 38112047)
1. An insight into the structure-activity relationship studies of anticancer medicinal attributes of 7-azaindole derivatives: a review.
Sharma N; Chaudhary A; Sachdeva M
Future Med Chem; 2023 Dec; 15(24):2309-2323. PubMed ID: 38112047
[TBL] [Abstract][Full Text] [Related]
2. The importance of indole and azaindole scaffold in the development of antitumor agents.
Han Y; Dong W; Guo Q; Li X; Huang L
Eur J Med Chem; 2020 Oct; 203():112506. PubMed ID: 32688198
[TBL] [Abstract][Full Text] [Related]
3. 7-Azaindole Analogues as Bioactive Agents and Recent Results.
Sharma N; Anurag
Mini Rev Med Chem; 2019; 19(9):727-736. PubMed ID: 30264679
[TBL] [Abstract][Full Text] [Related]
4. Azaindole therapeutic agents.
Motati DR; Amaradhi R; Ganesh T
Bioorg Med Chem; 2020 Dec; 28(24):115830. PubMed ID: 33161343
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound assisted one-pot synthesis of rosuvastatin based novel azaindole derivatives via coupling-cyclization strategy under Pd/Cu-catalysis: Their evaluation as potential cytotoxic agents.
Kumar JS; Reddy GS; Medishetti R; Amirul Hossain K; Thirupataiah B; Edelli J; Dilip Bele S; Kristina Edwin R; Joseph A; Shenoy GG; Mallikarjuna Rao C; Pal M
Bioorg Chem; 2022 Jul; 124():105857. PubMed ID: 35594765
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the global ring functionalization of 7-azaindoles.
Kannaboina P; Mondal K; Laha JK; Das P
Chem Commun (Camb); 2020 Oct; 56(79):11749-11762. PubMed ID: 32935671
[TBL] [Abstract][Full Text] [Related]
7. Recent advances of pyrrolopyridines derivatives: a patent and literature review.
El-Gamal MI; Anbar HS
Expert Opin Ther Pat; 2017 May; 27(5):591-606. PubMed ID: 28064544
[TBL] [Abstract][Full Text] [Related]
8. Current Fragment-to-lead Approaches Starting from the 7-azaindole: The Pharmacological Versatility of a Privileged Molecular Fragment.
Marcos Santos L; da Silveira NJF
Curr Top Med Chem; 2023; 23(22):2116-2130. PubMed ID: 37461366
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel 7-azaindole derivatives bearing dihydropyridazine moiety as c-Met kinase inhibitors.
Tang Q; Wang L; Duan Y; Wang W; Huang S; Zhi J; Jia S; Zhu W; Wang P; Luo R; Zheng P
Eur J Med Chem; 2017 Jun; 133():97-106. PubMed ID: 28384549
[TBL] [Abstract][Full Text] [Related]
10. In vitro anticancer active cis-Pt(II)-diiodido complexes containing 4-azaindoles.
Štarha P; Trávníček Z; Vančo J; Dvořák Z
J Biol Inorg Chem; 2019 Mar; 24(2):257-269. PubMed ID: 30767079
[TBL] [Abstract][Full Text] [Related]
11. Solvent-Free C-3 Coupling of Azaindoles with Cyclic Imines.
Belasri K; Fülöp F; Szatmári I
Molecules; 2019 Oct; 24(19):. PubMed ID: 31590280
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis and activity evaluation of PARP-1 inhibitors with azaindole skeleton].
Zhou J; Zhu ZX; Chen XG; Xu BL
Yao Xue Xue Bao; 2013 Dec; 48(12):1792-9. PubMed ID: 24689236
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities.
Hong S; Kim J; Seo JH; Jung KH; Hong SS; Hong S
J Med Chem; 2012 Jun; 55(11):5337-49. PubMed ID: 22575050
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel 7-azaindole derivatives containing pyridin-3-ylmethyl dithiocarbamate moiety as potent PKM2 activators and PKM2 nucleus translocation inhibitors.
Liu B; Yuan X; Xu B; Zhang H; Li R; Wang X; Ge Z; Li R
Eur J Med Chem; 2019 May; 170():1-15. PubMed ID: 30878825
[TBL] [Abstract][Full Text] [Related]
15. Azaindole derivatives as potential kinase inhibitors and their SARs elucidation.
Fang G; Chen H; Cheng Z; Tang Z; Wan Y
Eur J Med Chem; 2023 Oct; 258():115621. PubMed ID: 37423125
[TBL] [Abstract][Full Text] [Related]
16. Furanylazaindoles: potent anticancer agents in vitro and in vivo.
Lee HY; Pan SL; Su MC; Liu YM; Kuo CC; Chang YT; Wu JS; Nien CY; Mehndiratta S; Chang CY; Wu SY; Lai MJ; Chang JY; Liou JP
J Med Chem; 2013 Oct; 56(20):8008-18. PubMed ID: 24106982
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of 3-(2-phenyl-1,3-thiazol-4-yl)-1H-indoles and 3-(2-phenyl-1,3-thiazol-4-yl)-1H-7-azaindoles.
Diana P; Carbone A; Barraja P; Montalbano A; Parrino B; Lopergolo A; Pennati M; Zaffaroni N; Cirrincione G
ChemMedChem; 2011 Jul; 6(7):1300-9. PubMed ID: 21523912
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and In Vitro Evaluation of Novel Indolyl DiHydropyrazole Derivatives as Potential Anticancer Agents.
Venugopala KN; Habeebuddin M; Aldhubiab BE; Asif AH
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500672
[TBL] [Abstract][Full Text] [Related]
19. Exploring 6-Azaindole and 7-Azaindole Rings for Developing Cannabinoid Receptor 1 Allosteric Modulators.
Immadi SS; Dopart R; Wu Z; Fu B; Kendall DA; Lu D
Cannabis Cannabinoid Res; 2018; 3(1):252-258. PubMed ID: 30547095
[No Abstract] [Full Text] [Related]
20. How to modify 7-azaindole to form cytotoxic Pt(II) complexes: highly in vitro anticancer effective cisplatin derivatives involving halogeno-substituted 7-azaindole.
Štarha P; Trávníček Z; Popa A; Popa I; Muchová T; Brabec V
J Inorg Biochem; 2012 Oct; 115():57-63. PubMed ID: 22922312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
